Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-upJoost H. van den Berg, John B.A.G. Haanen, Ton N. Schumacher et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 196
Antigen‐specific TIL therapy for melanoma: A flexible platform for personalized cancer immunotherapySander Kelderman, Nina Schumacher, Mireille Toebes et al.|European Journal of Immunology|2016Cited by 41